Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis

Autor: Ozan Kahveci, Bulent Erdogan, Fatih Alagoz, Yahya Guvenc, Ucler Kisa, Ramazan Kahveci, Nurkan Aksoy, Aysun Gökçe, Berker Cemil, Mustafa F. Sargon, Emre Cemal Gokce
Přispěvatelé: Kırıkkale Üniversitesi, Zonguldak Bülent Ecevit Üniversitesi
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
thymoquinone
Apoptosis
medicine.disease_cause
Antioxidants
Random Allocation
chemistry.chemical_compound
0302 clinical medicine
Malondialdehyde
Benzoquinones
rat
Spinal cord injury
Thymoquinone
Motor Neurons
Caspase 3
General Medicine
Neuroprotective Agents
medicine.anatomical_structure
Spinal Cord
Methylprednisolone
Reperfusion Injury
Anesthesia
neuroprotection
medicine.symptom
medicine.drug
Neuroimmunomodulation
Inflammation
Nitric Oxide
Neuroprotection
03 medical and health sciences
medicine
Animals
Rats
Wistar

spinal cord ischemia-reperfusion injury
Spinal Cord Ischemia
Tumor Necrosis Factor-alpha
business.industry
medicine.disease
Spinal cord
methylprednisolone
spinal cord injury
Disease Models
Animal

Oxidative Stress
030104 developmental biology
chemistry
inflammation
business
Reperfusion injury
030217 neurology & neurosurgery
Oxidative stress
Interleukin-1
Zdroj: Journal of Neurosurgery: Spine. 24:949-959
ISSN: 1547-5654
DOI: 10.3171/2015.10.spine15612
Popis: OBJECTIVE Ischemia-reperfusion (I/R) injury of the spinal cord following thoracoabdominal aortic surgery remains the most devastating complication, with a life-changing impact on the patient. Thymoquinone (TQ), the main constituent of the volatile oil from Nigella sativa seeds, is reported to possess strong antioxidant, antiinflammatory, and antiapoptotic properties. This study investigated the effects of TQ administration following I/R injury to the spinal cord. METHODS Thirty-two rats were randomly allocated into 4 groups. Group 1 underwent only laparotomy. For Group 2, aortic clip occlusion was introduced to produce I/R injury. Group 3 was given 30 mg/kg of methylprednisolone intraperitoneally immediately after the I/R injury. Group 4 was given 10 mg/kg of TQ intraperitoneally for 7 days before induction of spinal cord I/R injury, and administration was continued until the animal was euthanized. Locomotor function (Basso, Beattie, and Bresnahan scale and inclined plane test) was assessed at 24 hours postischemia. Spinal cord tissue samples were harvested to analyze tissue concentrations of malondialdehyde, nitric oxide, tumor necrosis factor–α, interleukin-1, superoxide dismutase, glutathione-peroxidase, catalase, and caspase-3. In addition, histological and ultrastructural evaluations were performed. RESULTS Thymoquinone treatment improved neurological outcome, which was supported by decreased levels of oxidative products (malondialdehyde and nitric oxide) and proinflammatory cytokines (tumor necrosis factor–α and interleukin-1), increased activities of antioxidant enzymes (superoxide dismutase, glutathione-peroxidase, and catalase), as well as reduction of motor neuron apoptosis. Light microscopy and electron microscopy results also showed preservation of tissue structure in the treatment group. CONCLUSIONS As shown by functional, biochemical, histological, and ultrastructural analysis, TQ exhibits an important protective effect against I/R injury of the spinal cord.
Databáze: OpenAIRE